« Back to Record
Citation APA

Dal Lago, L., Durbecq, V., Desmedt, C., Salgado, R., Verjat, T., Lespagnard, L., Ma, Y., Veys, I., Di Leo, A., Sotiriou, C., Piccart-Gebhart, M., & Larsimont, D. (2006). Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. Molecular cancer therapeutics, 5(10), 2572-2579. doi:10.1158/1535-7163.MCT-06-0129


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/54753

Dal Lago, L., Durbecq, V., Desmedt, C., Salgado, R., Verjat, T., Lespagnard, L., Ma, Y., Veys, I., Di Leo, A., Sotiriou, C., Piccart-Gebhart, M., & Larsimont, D. (2006). Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. Molecular cancer therapeutics, 5(10), 2572-2579. doi:10.1158/1535-7163.MCT-06-0129